Correction to: Orally active opioid M/D dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice(Journal of Pharmacology and Experimental Therapeutics March (2014) 348: 3 (383-392) DOI:10.1124/jpet.113.208108)

K. Matsumoto; M. Narita; N. Muramatsu; T. Nakayama; K. Misawa; M. Kitajima; K. Tashima; L. A. Devi; T. Suzuki; H. Takayama; S. Horie

doi:10.1124/jpet.112.208108err

Correction to: Orally active opioid M/D dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice(Journal of Pharmacology and Experimental Therapeutics March (2014) 348: 3 (383-392) DOI:10.1124/jpet.113.208108)

K. Matsumoto, M. Narita, N. Muramatsu, T. Nakayama, K. Misawa, M. Kitajima, K. Tashima, L. A. Devi, T. Suzuki, H. Takayama, S. Horie

Research output: Contribution to journal › Comment/debate

Abstract

(2014) J Pharmacol Exp Ther 348(3):383–392; DOI:10.1124/jpet.113.208108], the following funding information was omitted: This work was funded by the National Institutes of Health [Grants DA 008863 and NS 026880]. The authors regret this error and any inconvenience it may have caused.

Original language	English
Pages (from-to)	142
Number of pages	1
Journal	Journal of Pharmacology and Experimental Therapeutics
Volume	369
Issue number	1
DOIs	https://doi.org/10.1124/jpet.112.208108err
State	Published - Apr 2019

Access to Document

10.1124/jpet.112.208108err

Fingerprint

Dive into the research topics of 'Correction to: Orally active opioid M/D dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice(Journal of Pharmacology and Experimental Therapeutics March (2014) 348: 3 (383-392) DOI:10.1124/jpet.113.208108)'. Together they form a unique fingerprint.

Cite this

Matsumoto, K., Narita, M., Muramatsu, N., Nakayama, T., Misawa, K., Kitajima, M., Tashima, K., Devi, L. A., Suzuki, T., Takayama, H., & Horie, S. (2019). Correction to: Orally active opioid M/D dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice(Journal of Pharmacology and Experimental Therapeutics March (2014) 348: 3 (383-392) DOI:10.1124/jpet.113.208108). Journal of Pharmacology and Experimental Therapeutics, 369(1), 142. https://doi.org/10.1124/jpet.112.208108err

Matsumoto, K. ; Narita, M. ; Muramatsu, N. et al. / Correction to : Orally active opioid M/D dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice(Journal of Pharmacology and Experimental Therapeutics March (2014) 348: 3 (383-392) DOI:10.1124/jpet.113.208108). In: Journal of Pharmacology and Experimental Therapeutics. 2019 ; Vol. 369, No. 1. pp. 142.

@article{dde18a0616954bdf9b117407d5e662c7,

title = "Correction to: Orally active opioid M/D dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice(Journal of Pharmacology and Experimental Therapeutics March (2014) 348: 3 (383-392) DOI:10.1124/jpet.113.208108)",

abstract = "(2014) J Pharmacol Exp Ther 348(3):383–392; DOI:10.1124/jpet.113.208108], the following funding information was omitted: This work was funded by the National Institutes of Health [Grants DA 008863 and NS 026880]. The authors regret this error and any inconvenience it may have caused.",

author = "K. Matsumoto and M. Narita and N. Muramatsu and T. Nakayama and K. Misawa and M. Kitajima and K. Tashima and Devi, {L. A.} and T. Suzuki and H. Takayama and S. Horie",

year = "2019",

month = apr,

doi = "10.1124/jpet.112.208108err",

language = "English",

volume = "369",

pages = "142",

journal = "Journal of Pharmacology and Experimental Therapeutics",

issn = "0022-3565",

publisher = "American Society for Pharmacology and Experimental Therapeutics",

number = "1",

}

Matsumoto, K, Narita, M, Muramatsu, N, Nakayama, T, Misawa, K, Kitajima, M, Tashima, K, Devi, LA, Suzuki, T, Takayama, H & Horie, S 2019, 'Correction to: Orally active opioid M/D dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice(Journal of Pharmacology and Experimental Therapeutics March (2014) 348: 3 (383-392) DOI:10.1124/jpet.113.208108)', Journal of Pharmacology and Experimental Therapeutics, vol. 369, no. 1, pp. 142. https://doi.org/10.1124/jpet.112.208108err

Correction to: Orally active opioid M/D dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice(Journal of Pharmacology and Experimental Therapeutics March (2014) 348: 3 (383-392) DOI:10.1124/jpet.113.208108). / Matsumoto, K.; Narita, M.; Muramatsu, N. et al.
In: Journal of Pharmacology and Experimental Therapeutics, Vol. 369, No. 1, 04.2019, p. 142.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Orally active opioid M/D dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice(Journal of Pharmacology and Experimental Therapeutics March (2014) 348: 3 (383-392) DOI:10.1124/jpet.113.208108)

AU - Matsumoto, K.

AU - Narita, M.

AU - Muramatsu, N.

AU - Nakayama, T.

AU - Misawa, K.

AU - Kitajima, M.

AU - Tashima, K.

AU - Devi, L. A.

AU - Suzuki, T.

AU - Takayama, H.

AU - Horie, S.

PY - 2019/4

Y1 - 2019/4

N2 - (2014) J Pharmacol Exp Ther 348(3):383–392; DOI:10.1124/jpet.113.208108], the following funding information was omitted: This work was funded by the National Institutes of Health [Grants DA 008863 and NS 026880]. The authors regret this error and any inconvenience it may have caused.

AB - (2014) J Pharmacol Exp Ther 348(3):383–392; DOI:10.1124/jpet.113.208108], the following funding information was omitted: This work was funded by the National Institutes of Health [Grants DA 008863 and NS 026880]. The authors regret this error and any inconvenience it may have caused.

UR - http://www.scopus.com/inward/record.url?scp=85063292559&partnerID=8YFLogxK

U2 - 10.1124/jpet.112.208108err

DO - 10.1124/jpet.112.208108err

M3 - Comment/debate

C2 - 30886001

AN - SCOPUS:85063292559

SN - 0022-3565

VL - 369

SP - 142

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

IS - 1

ER -

Matsumoto K, Narita M, Muramatsu N, Nakayama T, Misawa K, Kitajima M et al. Correction to: Orally active opioid M/D dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice(Journal of Pharmacology and Experimental Therapeutics March (2014) 348: 3 (383-392) DOI:10.1124/jpet.113.208108). Journal of Pharmacology and Experimental Therapeutics. 2019 Apr;369(1):142. doi: 10.1124/jpet.112.208108err